PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,871,000 | -54.2% | 979,016 | -57.5% | 0.06% | -59.6% |
| Q1 2018 | $17,204,000 | -8.2% | 2,306,184 | -26.8% | 0.15% | -9.9% |
| Q4 2017 | $18,747,000 | -19.2% | 3,150,808 | 0.0% | 0.16% | -13.8% |
| Q3 2017 | $23,190,000 | +8.4% | 3,150,808 | 0.0% | 0.19% | +0.5% |
| Q2 2017 | $21,394,000 | -28.1% | 3,150,808 | 0.0% | 0.19% | -23.0% |
| Q1 2017 | $29,744,000 | +9.3% | 3,150,808 | 0.0% | 0.24% | -9.0% |
| Q4 2016 | $27,223,000 | +17.8% | 3,150,808 | -13.7% | 0.27% | +27.1% |
| Q3 2016 | $23,110,000 | +37.9% | 3,650,808 | -8.0% | 0.21% | +19.3% |
| Q2 2016 | $16,754,000 | -11.7% | 3,970,250 | -8.7% | 0.18% | -12.0% |
| Q1 2016 | $18,970,000 | -28.9% | 4,350,808 | 0.0% | 0.20% | -9.5% |
| Q4 2015 | $26,670,000 | +7.2% | 4,350,808 | 0.0% | 0.22% | -3.9% |
| Q3 2015 | $24,887,000 | -23.3% | 4,350,808 | 0.0% | 0.23% | -19.3% |
| Q2 2015 | $32,457,000 | +24.7% | 4,350,808 | 0.0% | 0.28% | +31.9% |
| Q1 2015 | $26,018,000 | -22.7% | 4,350,808 | -2.2% | 0.22% | -37.0% |
| Q4 2014 | $33,640,000 | +45.7% | 4,449,797 | 0.0% | 0.34% | +17.9% |
| Q3 2014 | $23,094,000 | +20.4% | 4,449,797 | 0.0% | 0.29% | +23.8% |
| Q2 2014 | $19,179,000 | +5.4% | 4,449,797 | 0.0% | 0.24% | +1.7% |
| Q1 2014 | $18,200,000 | -18.7% | 4,449,797 | +5.9% | 0.23% | -26.7% |
| Q4 2013 | $22,386,000 | +6.2% | 4,200,000 | 0.0% | 0.32% | +5.0% |
| Q3 2013 | $21,084,000 | +12.6% | 4,200,000 | 0.0% | 0.30% | -19.1% |
| Q2 2013 | $18,732,000 | – | 4,200,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|